jump to navigation

FDA Approves Etex Bone Substitute, CarriGen 03/15/2010

Posted by Morse, Barnes-Brown Pendleton in Client News.
Tags: , ,
trackback

Etex CorporationMBBP client Etex Corporation, a Cambridge based biomaterials company, reports the FDA has approved its bone substitute product, CarriGen, which it will begin selling immediately. The product, which is a viscous putty made of nanocrystalline calcium phosphate, is a porous bone graft substitute that sets hard on implantation, filling the defect area and is intended to be used to fill holes in the bones of the pelvis, extremities and spine. The artificial bone material creates a scaffold-like structure comparatively as strong as natural bone.

For more information on CarriGen, please visit Etex Corporation.

Comments»

No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: